Durie Salmon Staging System Multiple Myeloma

Durie Salmon Staging System Multiple Myeloma. The new Durie/Salmon PLUS staging system integrates these new imaging techniques into a new generation of anatomic and functional myeloma staging It is possible to discriminate between the impact of tumour burden (myeloma cell mass) and other prognostic factors.

There are two ways to stage multiple myeloma DurieSalmon Staging System This is based on the levels of M protein calcium and red blood cells as well as the degree of bone damage International Staging System This is based on the levels of blood plasma and beta2.

How Many Stages Of Multiple Myeloma Cancer Are There?

Multiple Myeloma PrognosisDurieSalmon Staging SystemInternational Staging SystemRevised International Staging SystemA multiple myeloma prognosis is determined by both the number and specific properties of myeloma cells in a given patient These specific properties include the following 1 the growth rate of myeloma cells 2 the production rate of monoclonal proteins and 3 the production or nonproduction of various cytokines and chemi.

IS THE INTERNATIONAL STAGING SYSTEM SUPERIOR …

DurieSalmon System The DurieSalmon system has traditionally been used for the staging of myeloma This staging system is good for assessing the extent of the disease and/or size of the tumor According to this system there are 3 stages called stages I II or III (1 2 or 3).

Multiple Myeloma Prognosis Clinical Staging Systems

The DurieSalmon Staging System calculates the myeloma stage by measuring Hemoglobin concentration Level of blood calcium Presence of bone lesions on imaging studies to determine the extent of the myeloma Amount of the M protein in the blood and urine Level of kidney function International Staging System.